Immix Biopharma IMMX
NASDAQ IMMX
$10.01 -0.22 (-2.15%)
As of: Oct 2, 2026 · 12:50 PM EDT

Immix Biopharma (IMMX) Depreciation & Amortization (CF) (2021 - 2026)

Updated

Immix Biopharma's Depreciation & Amortization (CF) was $90,993 in Q2 2026, up 55.6% from $58,494 a year earlier but down 0.6% from the prior quarter.

Analysis

Immix Biopharma (IMMX) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Immix Biopharma's Depreciation & Amortization (CF) was $331,670 through Jun 30, 2026, up 140.6% year-over-year; for FY2025, it was $245,747, up 198.1% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 154.1% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $82,447 in FY2024, $5,468 in FY2023 (+156.1%), $2,135 in FY2022 (-13.5%) and $2,468 in FY2021 (+6.3%).
  • Quarterly Depreciation & Amortization (CF) has moved between $383.00 (Q2 2022) and $96,986 (Q3 2025) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for seven straight quarters, with growth averaging 223.5% over the last seven quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2024 (growth of 574.1%); the worst was Q2 2022 (a decline of 38.2%).
  • Per Business Quant data, IMMX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $91,577 (Q1 2026), $52,114 (Q4 2025) and $96,986 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Immix Biopharma 743.97 Mn 743.97 Mn - 90,993.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90,993.00
Mar 31, 2026 91,577.00
Dec 31, 2025 52,114.00
Sep 30, 2025 96,986.00
Jun 30, 2025 58,494.00
Mar 31, 2025 38,153.00
Dec 31, 2024 20,734.00
Sep 30, 2024 20,457.00
Jun 30, 2024 20,416.00
Mar 31, 2024 20,840.00
Dec 31, 2023 3,076.00
Sep 30, 2023 1,381.00
Jun 30, 2023 506.00
Mar 31, 2023 505.00
Dec 31, 2022 566.00
Sep 30, 2022 566.00
Jun 30, 2022 383.00
Mar 31, 2022 620.00
Dec 31, 2021 620.00
Sep 30, 2021 620.00
API Access

Immix Biopharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IMMX&period=max&api_key=YOUR_API_KEY